News
Eli Lilly's acquisition of Vere Therapeutics promises to revolutionize cardiovascular care with innovative one-time gene ...
2d
MyChesCo on MSNAstraZeneca Unveils $50 Billion U.S. Investment Plan, Anchored by Massive Virginia Manufacturing Site
AstraZeneca has announced a sweeping $50 billion investment across the United States through 2030, marking the company’s largest commitment to U.S. pharmaceutical operations to date. The move signals ...
The most common type of cholesterol-lowering drugs are statins, with brand names like Lipitor and Crestor. These work by ...
"attachment_1199068" align="aligncenter" width="1456"] A pharmacy worker distributing prescription medicines to ...
AstraZeneca's strategic $50B investment promises to revolutionize U.S. medicine production with advanced manufacturing and ...
AstraZeneca, a pharmaceutical company, has announced its plans to bring a drug substance manufacturing facility to Virginia.
Statins have been used for many years and are known to be safe for most people. But some people may notice unexpected changes ...
AstraZeneca plans to construct a multi-billion dollar manufacturing center focused on chronic diseases in Virginia within the next five years.
AstraZeneca plans a $50 billion investment in U.S. facilities by 2030, including a Virginia plant focused on weight loss and ...
Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.
AstraZeneca has announced a $50 billion investment in the United States by 2030, creating tens of thousands of new, highly ...
Adding to the string of US and international drugmakers investment in US production investment following a call from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results